Nadja Alt

1.0k total citations
9 papers, 838 citations indexed

About

Nadja Alt is a scholar working on Molecular Biology, Clinical Biochemistry and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Nadja Alt has authored 9 papers receiving a total of 838 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Clinical Biochemistry and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Nadja Alt's work include Advanced Glycation End Products research (4 papers), Biochemical effects in animals (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Nadja Alt is often cited by papers focused on Advanced Glycation End Products research (4 papers), Biochemical effects in animals (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Nadja Alt collaborates with scholars based in Germany, United States and Switzerland. Nadja Alt's co-authors include John Baynes, Suzanne R. Thorpe, Paul A. Motchnik, Valerie Quarmby, Reed J. Harris, Thomas Emrich, Tilman Schlothauer, Hermann Beck, James A. Carson and Ryoji Nagai and has published in prestigious journals such as American Journal of Clinical Nutrition, Journal of Agricultural and Food Chemistry and Annals of the New York Academy of Sciences.

In The Last Decade

Nadja Alt

9 papers receiving 818 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nadja Alt Germany 8 502 235 233 139 116 9 838
T Nishida Japan 16 425 0.8× 21 0.1× 58 0.2× 238 1.7× 52 0.4× 35 957
Chin-Wen Chi Taiwan 14 448 0.9× 31 0.1× 46 0.2× 36 0.3× 32 0.3× 27 776
Hamda Khan India 9 129 0.3× 20 0.1× 197 0.8× 117 0.8× 37 0.3× 22 397
Thomas C. Dembinski Canada 12 326 0.6× 33 0.1× 15 0.1× 94 0.7× 33 0.3× 27 695
N. Domingo France 18 305 0.6× 20 0.1× 33 0.1× 96 0.7× 72 0.6× 60 841
Joe Palandra United States 15 282 0.6× 36 0.2× 16 0.1× 16 0.1× 75 0.6× 25 838
Patrick M. Hutchins United States 16 312 0.6× 11 0.0× 35 0.2× 333 2.4× 70 0.6× 19 915
Pei-Ran Wang United States 11 271 0.5× 35 0.1× 10 0.0× 129 0.9× 96 0.8× 13 746
Yuichiro SAKAMOTO Japan 12 209 0.4× 9 0.0× 106 0.5× 232 1.7× 32 0.3× 28 683
Jiawen Yu China 13 505 1.0× 23 0.1× 15 0.1× 113 0.8× 48 0.4× 27 819

Countries citing papers authored by Nadja Alt

Since Specialization
Citations

This map shows the geographic impact of Nadja Alt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nadja Alt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nadja Alt more than expected).

Fields of papers citing papers by Nadja Alt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nadja Alt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nadja Alt. The network helps show where Nadja Alt may publish in the future.

Co-authorship network of co-authors of Nadja Alt

This figure shows the co-authorship network connecting the top 25 collaborators of Nadja Alt. A scholar is included among the top collaborators of Nadja Alt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nadja Alt. Nadja Alt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Alt, Nadja, Paul A. Motchnik, Valerie Quarmby, et al.. (2016). Determination of critical quality attributes for monoclonal antibodies using quality by design principles. Biologicals. 44(5). 291–305. 202 indexed citations
2.
Reusch, Dietmar, Markus Haberger, B.P.K. Maier, et al.. (2014). Comparison of methods for the analysis of therapeutic immunoglobulin G Fc-glycosylation profiles—Part 1: Separation-based methods. mAbs. 7(1). 167–179. 132 indexed citations
3.
Alt, Nadja, Katharina Diepold, Patrick Bulau, et al.. (2012). Analytical Protein A Chromatography as a Quantitative Tool for the Screening of Methionine Oxidation in Monoclonal Antibodies. Journal of Pharmaceutical Sciences. 101(11). 4248–4257. 37 indexed citations
4.
Birlouez‐Aragon, Inès, Frédéric J. Tessier, Anne Galinier, et al.. (2010). A diet based on high-heat-treated foods promotes risk factors for diabetes mellitus and cardiovascular diseases. American Journal of Clinical Nutrition. 91(5). 1220–1226. 199 indexed citations
5.
Alderson, Nathan L., Yuping Wang, Matthew Blatnik, et al.. (2006). S-(2-Succinyl)cysteine: A novel chemical modification of tissue proteins by a Krebs cycle intermediate. Archives of Biochemistry and Biophysics. 450(1). 1–8. 153 indexed citations
6.
Brown, Sarah M., et al.. (2005). Tissue‐Specific Variation in Glycation of Proteins in Diabetes: Evidence for a Functional Role of Amadoriase Enzymes. Annals of the New York Academy of Sciences. 1043(1). 817–823. 31 indexed citations
7.
Alt, Nadja & Peter Schieberle. (2005). Identification of N7‐(1‐Carboxyethyl)‐Arginine, a Novel Posttranslational Protein Modification of Arginine Formed at High Hydrostatic Pressure. Annals of the New York Academy of Sciences. 1043(1). 55–58. 5 indexed citations
8.
Alt, Nadja & Peter Schieberle. (2005). Model Studies on the Influence of High Hydrostatic Pressure on the Formation of Glycated Arginine Modifications at Elevated Temperatures. Journal of Agricultural and Food Chemistry. 53(14). 5789–5797. 23 indexed citations
9.
Alt, Nadja, James A. Carson, Nathan L. Alderson, et al.. (2004). Chemical modification of muscle protein in diabetes. Archives of Biochemistry and Biophysics. 425(2). 200–206. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026